HOTAIR and non-small cell lung carcinoma: Thus, this study suggests that therapeutic regulation of miR‐34a‐5p‐ and HOTAIR‐mediated inhibition of EMT may provide an opportunity to control NSCLC growth and metastasis by the combination of BBR and gefitinib .